Geagonia, Jay Lyka M.

HRN: 25-48-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2024
AMPICILLIN 1GM (VIAL)
09/09/2024
09/16/2024
IVT
2grams
Q6
PROM X 30 HRS
Waiting Final Action 
09/13/2024
CEFUROXIME 1.5GM (VIAL)
09/13/2024
09/16/2024
IVT
1.5grams
Q8
S/P LTCS
Waiting Final Action 
09/14/2024
CEFUROXIME 500MG (TAB)
09/14/2024
09/20/2024
ORAL
500mg
2 Times A Day
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: